Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia
- PMID: 19643774
- DOI: 10.1093/jac/dkp271
Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia
Abstract
Objectives: Stenotrophomonas maltophilia is an emerging nosocomial pathogen that can cause difficult-to-treat infections and exhibits significant degrees of poorly understood multidrug resistance (MDR). The aim of this study was to identify and characterize a multidrug ATP-binding cassette (ABC) efflux pump in S. maltophilia.
Methods: SmrA was identified in the S. maltophilia genome based on the detection of ABC transporter conserved motifs and alignment with experimentally proven MDR ABC transporters. The smrA gene was cloned and expressed in the hypersusceptible acrAB mutant Escherichia coli strain SM1411. The resistance to several antimicrobial agents was tested using Stokes' disc diffusion and broth microdilution MIC methods. Norfloxacin accumulation and efflux assays were performed using a fluorescence method with and without the efflux pump inhibitors sodium O-vanadate and reserpine.
Results: Cloning and expression of smrA in Escherichia coli conferred increased resistance to structurally unrelated compounds, including fluoroquinolones, tetracycline, doxorubicin and multiple dyes. Moreover, the expression of smrA in E. coli reduced norfloxacin uptake and enhanced its efflux, features that could be inhibited by the ABC efflux pump inhibitors.
Conclusions: SmrA is a member of the ABC multidrug efflux pump family. The findings warrant further study of the role of this molecule in S. maltophilia isolates, to estimate the potential impact of this system in antimicrobial resistance.
Similar articles
-
Cloning and Functional Characterization of Putative Escherichia coli ABC Multidrug Efflux Transporter YddA.J Microbiol Biotechnol. 2020 Jul 28;30(7):982-995. doi: 10.4014/jmb.2003.03003. J Microbiol Biotechnol. 2020. PMID: 32347079 Free PMC article.
-
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.Int J Environ Res Public Health. 2015 May 13;12(5):5177-95. doi: 10.3390/ijerph120505177. Int J Environ Res Public Health. 2015. PMID: 25985315 Free PMC article.
-
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.Antimicrob Agents Chemother. 2000 Feb;44(2):287-93. doi: 10.1128/AAC.44.2.287-293.2000. Antimicrob Agents Chemother. 2000. PMID: 10639352 Free PMC article.
-
[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].Mikrobiyol Bul. 2007 Apr;41(2):309-27. Mikrobiyol Bul. 2007. PMID: 17682720 Review. Turkish.
-
Antimicrobial therapy for Stenotrophomonas maltophilia infections.Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):229-37. doi: 10.1007/s10096-007-0279-3. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17334747 Review.
Cited by
-
A Putative ABC Transporter Permease Is Necessary for Resistance to Acidified Nitrite and EDTA in Pseudomonas aeruginosa under Aerobic and Anaerobic Planktonic and Biofilm Conditions.Front Microbiol. 2016 Apr 1;7:291. doi: 10.3389/fmicb.2016.00291. eCollection 2016. Front Microbiol. 2016. PMID: 27064218 Free PMC article.
-
The inactivation of RNase G reduces the Stenotrophomonas maltophilia susceptibility to quinolones by triggering the heat shock response.Front Microbiol. 2015 Oct 19;6:1068. doi: 10.3389/fmicb.2015.01068. eCollection 2015. Front Microbiol. 2015. PMID: 26539164 Free PMC article.
-
Novel Mechanisms of Efflux-Mediated Levofloxacin Resistance and Reduced Amikacin Susceptibility in Stenotrophomonas maltophilia.Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01284-20. doi: 10.1128/AAC.01284-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33139281 Free PMC article.
-
Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing.J Antimicrob Chemother. 2015 Jul;70(7):1946-59. doi: 10.1093/jac/dkv060. Epub 2015 Apr 9. J Antimicrob Chemother. 2015. PMID: 25862682 Free PMC article.
-
Clinical challenges treating Stenotrophomonas maltophilia infections: an update.JAC Antimicrob Resist. 2022 May 5;4(3):dlac040. doi: 10.1093/jacamr/dlac040. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35529051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources